Platinum antitumour agents, containing aromatic rings, which are used for targeting DNA in effective therapies for the treatment of cancer. We have synthesized the title metallocomplex with an aromatic ligand and determined its crystal structure. In many cases, complexes of platinum and other metals have a symmetrical structure. In contrast, the platinum(II) complex with pyridine and N-(9-anthracenylmethyl)-1,2-ethanediamine as ligands (systematic name: cis-N-[(anthracen-9-yl)methyl]ethane-1,2-diamine-κ2
N,N′}bis(pyridine-κN)platinum(II) dinitrate), [Pt(C5H5N)2(C17H18N2)](NO3)2, is asymmetric. Of the two pyridine ligands, only one is π-stacked with anthracene, resulting in an asymmetric structure. Moreover, the angle of orientation of each pyridine ligand is variable. Further examination of the packing motif confirms an intermolecular edge-to-face interaction.
含有芳香环的铂类抗肿瘤药,可用于靶向 DNA 的癌症有效疗法。我们合成了含有芳香配体的金属络合物,并测定了其晶体结构。在许多情况下,铂和其他金属的络合物具有对称结构。相反,以吡啶和 N-(9-蒽甲基)-1,2-乙二胺为配体的铂(II)络合物(系统名称:顺式-N-[(蒽-9-基)甲基]乙烷-1,2-二胺-κ2
N,N′}双(吡啶-κN)二硝酸铂(II),[Pt(C5H5N)2(C17H18N2)](NO3)2,是不对称的。在两个吡啶配体中,只有一个与蒽进行了π堆叠,从而形成了不对称结构。此外,每个吡啶配体的取向角度都是可变的。对填料图案的进一步研究证实了分子间边对面的相互作用。